237 related articles for article (PubMed ID: 22375523)
21. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
[TBL] [Abstract][Full Text] [Related]
23. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
[TBL] [Abstract][Full Text] [Related]
25. An unusual presentation of hepatocellular carcinoma: case report and review.
Silverstein N; Forouhar F; Rossi L; Aziz K
Conn Med; 2005 Mar; 69(3):133-8. PubMed ID: 15861998
[TBL] [Abstract][Full Text] [Related]
26. Multimodality management of hepatocellular carcinoma larger than 10 cm.
Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
[TBL] [Abstract][Full Text] [Related]
27. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J
Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346
[TBL] [Abstract][Full Text] [Related]
28. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hepatocellular carcinoma: medical options.
Fried MW
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S92-7. PubMed ID: 9742500
[TBL] [Abstract][Full Text] [Related]
31. [A small-sized hepatocellular carcinoma].
Barbare JC
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B159-64. PubMed ID: 12843953
[No Abstract] [Full Text] [Related]
32. [Hepatocellular carcinoma: a multidisciplinary approach].
Tempia-Caliera AA; Ksontini R; Moradpour D; Denys A; Halkic N
Rev Med Suisse; 2005 Jun; 1(24):1621-4, 1627-9. PubMed ID: 16028708
[TBL] [Abstract][Full Text] [Related]
33. Current approaches to the diagnosis and management of hepatocellular carcinoma.
Perry JF; Poustchi H; George J; Farrell GC; McCaughan GW; Strasser SI
Clin Exp Med; 2005 May; 5(1):1-13. PubMed ID: 15928877
[TBL] [Abstract][Full Text] [Related]
34. Opportunities for targeted therapies in hepatocellular carcinoma.
Thomas MB; Abbruzzese JL
J Clin Oncol; 2005 Nov; 23(31):8093-108. PubMed ID: 16258107
[TBL] [Abstract][Full Text] [Related]
35. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
[TBL] [Abstract][Full Text] [Related]
36. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
37. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis and selection of treatment modalities for hepatocellular carcinoma].
Okamura J; Monden M; Sakon M; Mori T; Kuroda C; Sakurai M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):203-9. PubMed ID: 3004362
[TBL] [Abstract][Full Text] [Related]
39. [Practice guidelines for management of hepatocellular carcinoma 2009].
Korean Liver Cancer Study Group and National Cancer Center, Korea
Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
